会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 51. 发明申请
    • ETHERNET ENHANCEMENTS
    • 以太网增强
    • US20150117177A1
    • 2015-04-30
    • US14496667
    • 2014-09-25
    • Ilango GangaAlain GravelThomas LovettRadia PerlmanGreg RegnierAnil VasudevanHugh Wilkinson
    • Ilango GangaAlain GravelThomas LovettRadia PerlmanGreg RegnierAnil VasudevanHugh Wilkinson
    • H04L12/939H04L12/861H04L1/16
    • H04L49/552H04L1/1621H04L49/251H04L49/9057
    • This disclosure describes enhancements to Ethernet for use in higher performance applications like Storage, HPC, and Ethernet based fabric interconnects. This disclosure provides various mechanisms for lossless fabric enhancements with error-detection and retransmissions to improve link reliability, frame pre-emption to allow higher priority traffic over lower priority traffic, virtual channel support for deadlock avoidance by enhancing Class of service functionality defined in IEEE 802.1Q, a new header format for efficient forwarding/routing in the fabric interconnect and header CRC for reliable cut-through forwarding in the fabric interconnect. The enhancements described herein, when added to standard and/or proprietary Ethernet protocols, broadens the applicability of Ethernet to newer usage models and fabric interconnects that are currently served by alternate fabric technologies like Infiniband, Fibre Channel and/or other proprietary technologies, etc.
    • 本公开描述了对以太网的增强功能,用于诸如Storage,HPC和以太网的架构互连之类的更高性能应用。 本公开提供了用于具有错误检测和重传的无损结构增强的各种机制,以改善链路可靠性,帧优先级以允许在较低优先级业务上的较高优先级业务,通过增强IEEE802.11定义的服务功能类别来提供对死锁避免的虚拟信道支持 Q,用于架构互连中的高效转发/路由的新标题格式,以及用于结构互连中可靠的直通转发的报头CRC。 此处描述的增强功能在添加到标准和/或专有以太网协议时,将以太网适用于当前由诸如Infiniband,光纤通道和/或其他专有技术之类的备用架构技术所服务的较新的使用模式和架构互连。
    • 52. 发明申请
    • Adaptive Queuing of a Cache for a Processing Element
    • 处理元素缓存的自适应队列
    • US20130262718A1
    • 2013-10-03
    • US13436337
    • 2012-03-30
    • Anil VasudevanGlenn J. HintonYadong Li
    • Anil VasudevanGlenn J. HintonYadong Li
    • G06F3/00
    • G06F12/084G06F5/10H04L49/90
    • Examples are disclosed for establishing a window for a queue structure maintained in a cache for a processing element for a network device. The processing element may be configured to operate in cooperation with an input/output device such as a network interface card. In some of these examples, the window may include portions of the queue structure having identifiers to active allocated buffers maintained in memory for the network device. The active allocated buffers may be configured to maintain or store data received or to be forwarded by the input/output device. For these examples, the window may be adjusted based on information gathered while the identifiers are read from or written to the portions of the queue structure.
    • 公开了用于建立用于网络设备的处理元件的高速缓存中维护的队列结构的窗口的示例。 处理元件可以被配置为与诸如网络接口卡的输入/输出设备协作操作。 在这些示例中的一些示例中,窗口可以包括具有对于网络设备的存储器中维护的主动分配缓冲区的标识符的队列结构的部分。 活动分配的缓冲器可以被配置为维护或存储由输入/输出设备接收或要转发的数据。 对于这些示例,可以基于从标识符从队列结构的部分读取或写入标识符时收集的信息来调整窗口。
    • 54. 发明授权
    • 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
    • 4-(4-吡啶基) - 苯甲酰胺及其作为岩石活性调节剂的用途
    • US08445686B2
    • 2013-05-21
    • US12675430
    • 2008-08-26
    • Helmut MackNicole TeuschBernhard K. MuellerWilfried HornbergerMichael F. JarvisDaryl SauerSteve Swann, Jr.Dominique BonafouxRyan KeddyAdrian Donald HobsonAnil Vasudevan
    • Helmut MackNicole TeuschBernhard K. MuellerWilfried HornbergerMichael F. JarvisDaryl SauerSteve Swann, Jr.Dominique BonafouxRyan KeddyAdrian Donald HobsonAnil Vasudevan
    • C07D211/78C07D211/72C07D211/84A61K31/44
    • C07D401/12C07D213/56C07D405/12C07D409/12C07D413/12C07D413/14C07D417/12
    • The present invention relates to novel 4-(4-pyridyl)-benzamides of the formula (I). The compounds I possess valuable therapeutic properties and are suitable, in particular, for treating diseases that respond to modulation of Rho kinases (ROCKs). R1 and R2 are, independently of each other, hydrogen, hydroxy, cyano, C1-C8-alkyl, C1-C8-haloalkyl, C1-C8-alkoxy or C1-C8-haloalkoxy; R3, R4, R5 and R6 are, independently of each other, hydrogen, hydroxy, halogen, cyano, C1-C8-alkyl, C1-C8-haloalkyl, C1-C8-alkoxy, C1-C8-haloalkoxy, amino, C1-C8-alkylamino or di-(C1-C8-alkyl)-amino; R7 is hydrogen, C1-C8-alkyl, C1-C8-haloalkyl, aryl or aryl-C1-C8-alkyl; R8 is a group of the formula —X—W, where X is a single bond, C1-C4-alkylene or C1-C4-alkylene-O—, where the alkylene group in the three last-mentioned radicals may be linear or branched and may be partly or fully halogenated and/or may be substituted by a hydroxyl group and/or may be interrupted by an oxygen atom; and W is a cyclic radical selected from phenyl and a 5- or 6-membered saturated, partly unsaturated or aromatic heterocyclic ring which contains as ring members 1, 2 or 3 heteroatoms selected from O, S and N and optionally 1 or 2 carbonyl groups; R9 is a group of the formula —Y—Z, where Z is hydrogen, halogen, OR11, NR12R13, S(O)m—R14, phenyl which may carry 1, 2, 3 or 4 substituents R15 or a 5- or 6-membered saturated, partly unsaturated or aromatic heterocyclic ring; and Y is linear or branched C1C4-alkylene which may be partly or fully halogenated and/or may be substituted by a hydroxyl group and/or a phenyl ring; or, in case Z is phenyl or the 5- or 6-membered heterocyclic ring as defined above, Y can also be a single bond.
    • 本发明涉及式(I)的新型4-(4-吡啶基) - 苯甲酰胺。 化合物I具有有价值的治疗特性,特别适用于治疗对Rho激酶(ROCK)的调节作用的疾病。 R 1和R 2彼此独立地为氢,羟基,氰基,C 1 -C 8 - 烷基,C 1 -C 8 - 卤代烷基,C 1 -C 8 - 烷氧基或C 1 -C 8 - 卤代烷氧基; R3,R4,R5和R6彼此独立地为氢,羟基,卤素,氰基,C1-C8-烷基,C1-C8-卤代烷基,C1-C8-烷氧基,C1-C8-卤代烷氧基,氨基,C1- C 8 - 烷基氨基或二 - (C 1 -C 8 - 烷基) - 氨基; R 7是氢,C 1 -C 8 - 烷基,C 1 -C 8 - 卤代烷基,芳基或芳基-C 1 -C 8 - 烷基; R8是式-XW的基团,其中X是单键,C1-C4-亚烷基或C1-C4-亚烷基-O-,其中三个最后提及的基团中的亚烷基可以是直链或支链的,并且可以 部分或完全卤化和/或可以被羟基取代和/或可被氧原子中断; 并且W是选自苯基和5-或6-元饱和,部分不饱和或芳族杂环的环状基团,其含有作为环成员1,2或3的选自O,S和N的杂原子以及任选的1或2个羰基 ; R9是式-YZ的基团,其中Z是氢,卤素,OR11,NR12R13,S(O)m -R14,可以带有1,2,3或4个取代基R15或5-或6-元的苯基 饱和,部分不饱和或芳族杂环; Y是可部分或完全卤化和/或可被羟基和/或苯环取代的直链或支链C 1 -C 4亚烷基; 或者Z为苯基或上述5-或6-元杂环的情况下,Y也可以是单键。